GluBio Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch GluBio Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes (NCT06146257) | GluBio Therapeutics Inc. | 2024-01-11 |
Track GluBio Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.